Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 1INDIV 1

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 1484Neoplasms 1100Carcinoma, Non-Small-Cell Lung 915Prostatic Neoplasms 800Multiple Myeloma 584Colorectal Neoplasms 533Leukemia, Myeloid, Acute 500Lung Neoplasms 489Lymphoma 454Melanoma 452Neoplasm Metastasis 450Lymphoma, Non-Hodgkin 415Leukemia 407Leukemia, Lymphocytic, Chronic, B-Cell 366Ovarian Neoplasms 356Pancreatic Neoplasms 338Precursor Cell Lymphoblastic Leukemia-Lymphoma 331Recurrence 315Lymphoma, Follicular 297Head and Neck Neoplasms 297Myelodysplastic Syndromes 280Carcinoma, Renal Cell 272Glioblastoma 266Brain Neoplasms 265Hodgkin Disease 260Lymphoma, Large B-Cell, Diffuse 255Carcinoma, Hepatocellular 241Lymphoma, Mantle-Cell 219Squamous Cell Carcinoma of Head and Neck 214Stomach Neoplasms 208

Interventions

macimorelin 1Omacor 1Eicosapentaenoic Acid 1Docosahexaenoic Acids 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Has results × Cancer Cachexia × Clear all
NCT01614990 2024-03-20

Pilot Clinical Trial of Repeated Doses of Macimorelin to Assess Safety and Efficacy in Patients With Cancer Cachexia

Garcia, Jose M., MD, PhD

Phase 2 Completed
15 enrolled 35 charts

Cancer Cachexia

NCT00815685 2017-03-23

A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
36 enrolled 7 charts

Cancer Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡